Stephen Baxter
Stock Analyst at Wells Fargo
(3.04)
# 1,309
Out of 4,876 analysts
179
Total ratings
42.48%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PNTG The Pennant Group | Maintains: Equal-Weight | $30 → $31 | $29.09 | +6.57% | 1 | Jun 3, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $691 → $766 | $722.00 | +6.09% | 6 | Jun 3, 2025 | |
| COR Cencora | Upgrades: Overweight | $274 → $337 | $296.58 | +13.63% | 3 | Jun 3, 2025 | |
| CAH Cardinal Health | Upgrades: Overweight | $136 → $179 | $165.61 | +8.09% | 7 | Jun 3, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2 → $3.5 | $3.48 | +0.57% | 9 | May 29, 2025 | |
| HCA HCA Healthcare | Upgrades: Equal-Weight | $320 → $385 | $377.66 | +1.94% | 14 | May 29, 2025 | |
| THC Tenet Healthcare | Upgrades: Overweight | $150 → $195 | $172.56 | +13.00% | 13 | May 29, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $677 → $351 | $302.62 | +15.99% | 11 | May 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $27 | $23.08 | +16.98% | 4 | May 13, 2025 | |
| AGL agilon health | Maintains: Overweight | $6 → $5 | $2.31 | +116.45% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $68.14 | +23.28% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $16 | $20.48 | -21.88% | 10 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $225 | $177.43 | +26.81% | 13 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $295 → $372 | $291.06 | +27.81% | 17 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $72 | $53.57 | +34.40% | 21 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $370 → $341 | $330.00 | +3.33% | 7 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $373.18 | +28.09% | 9 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $239.90 | +20.88% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $8.05 | +86.34% | 3 | Apr 29, 2024 |
The Pennant Group
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $30 → $31
Current: $29.09
Upside: +6.57%
McKesson
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $691 → $766
Current: $722.00
Upside: +6.09%
Cencora
Jun 3, 2025
Upgrades: Overweight
Price Target: $274 → $337
Current: $296.58
Upside: +13.63%
Cardinal Health
Jun 3, 2025
Upgrades: Overweight
Price Target: $136 → $179
Current: $165.61
Upside: +8.09%
Community Health Systems
May 29, 2025
Maintains: Underweight
Price Target: $2 → $3.5
Current: $3.48
Upside: +0.57%
HCA Healthcare
May 29, 2025
Upgrades: Equal-Weight
Price Target: $320 → $385
Current: $377.66
Upside: +1.94%
Tenet Healthcare
May 29, 2025
Upgrades: Overweight
Price Target: $150 → $195
Current: $172.56
Upside: +13.00%
UnitedHealth Group
May 14, 2025
Maintains: Overweight
Price Target: $677 → $351
Current: $302.62
Upside: +15.99%
BrightSpring Health Services
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $23.08
Upside: +16.98%
agilon health
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.31
Upside: +116.45%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $68.14
Upside: +23.28%
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $20.48
Upside: -21.88%
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $177.43
Upside: +26.81%
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $291.06
Upside: +27.81%
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $53.57
Upside: +34.40%
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $330.00
Upside: +3.33%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $373.18
Upside: +28.09%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $239.90
Upside: +20.88%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $8.05
Upside: +86.34%